ERLINA PLUS XR 12.5/2.5/1000MG TAB

ERLINA PLUS XR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin HCL 1000mg—three potent ingredients working synergistically to help regulate blood sugar levels. This extended-release formulation provides sustained therapeutic effect throughout the day, reducing the need for multiple daily doses. Empagliflozin supports glucose excretion through the kidneys, Linagliptin enhances insulin secretion, and Metformin improves insulin sensitivity and reduces hepatic glucose production. Ideal for patients with type 2 diabetes requiring multi-drug therapy. Consult your healthcare provider to determine if ERLINA PLUS XR is appropriate for your treatment plan.